SMAD4 and breast cancer: Using a cellular and mouse model of TGF-β-induced breast cancer progression, Dekers et al. demonstrated that Smad4 is required for TGF-β induced EMT and bone metastasis of breast cancer cells (Deckers et al., 2006).